Subjects

Drugs

348 bills across 7 sessions, from the Legislature's subject index.

• AB 50 Relating to: state finances and appropriations, constituting the executive budget act of the 2025 legislature. (FE) Died at session end 2025
• AB 54 Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE) Died at session end 2025
• AB 62 Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) Died at session end 2025
• AB 68 Relating to: the prescription drug monitoring program. (FE) Died at session end 2025
• SB 45 Relating to: state finances and appropriations, constituting the executive budget act of the 2025 legislature. (FE) Became law 2025
• SB 50 Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) Died at session end 2025
• SB 68 Relating to: the prescription drug monitoring program. (FE) Became law 2025
• SB 83 Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE) Died at session end 2025
• AB 127 Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE) Died at session end 2025
• AB 128 Relating to: requiring first responders to be trained to administer epinephrine delivery systems. (FE) Died at session end 2025
• AB 173 Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) Died at session end 2025
• AB 246 Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE) Died at session end 2025
• AB 257 Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Became law 2025
• AB 355 Relating to: right to bodily autonomy, elimination of certain abortion-related regulations, and coverage of abortion under certain health care coverage plans. (FE) Died at session end 2025
• AB 499 Relating to: coverage of nonopioid drug alternatives for the treatment and management of pain. Died at session end 2025
• AB 547 Relating to: regulating medical cannabis, the prescription drug monitoring program, and providing a penalty. (FE) Died at session end 2025
• AB 589 Relating to: elimination of certain abortion-related regulations. Died at session end 2025
• AB 607 Relating to: housing and homelessness; emergency rental assistance program; indigent civil legal services; workforce development; community action agencies; poverty reports; mental health; economic security; reimbursement for nonemergency medical transportation services; urban mass transit aid; lead exposure and abatement services; lead service line replacement; providing an exemption from emergency rule procedures; granting rule-making authority; and making an appropriation. (FE) Died at session end 2025
• AB 639 Relating to: naturopathic doctors. (FE) Died at session end 2025
• AB 680 Relating to: prohibiting individuals under age 21 from accessing intoxicating hemp products and providing a penalty. (FE) Died at session end 2025
• AB 718 Relating to: prescription, use, and disposal of abortion-inducing drugs and providing a penalty. Died at session end 2025
• AB 774 Relating to: prohibiting step therapy protocols for certain cancer drugs. Died at session end 2025
• AB 775 Relating to: cost-sharing cap on epinephrine delivery systems under health insurance policies and plans. (FE) Died at session end 2025
• AB 921 Relating to: cost-sharing cap on insulin. Died at session end 2025
• AB 969 Relating to: the drug repository program. Became law 2025
• SB 137 Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE) Died at session end 2025
• SB 156 Relating to: requiring first responders to be trained to administer epinephrine delivery systems. (FE) Died at session end 2025
• SB 203 Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) Died at session end 2025
• SB 251 Relating to: cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE) Died at session end 2025
• SB 258 Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Died at session end 2025
• SB 271 Relating to: right to bodily autonomy, elimination of certain abortion-related regulations, and coverage of abortion under certain health care coverage plans. (FE) Died at session end 2025
• SB 492 Relating to: coverage of nonopioid drug alternatives for the treatment and management of pain. Died at session end 2025
• SB 534 Relating to: regulating medical cannabis, the prescription drug monitoring program, and providing a penalty. (FE) Died at session end 2025
• SB 547 Relating to: elimination of certain abortion-related regulations. Died at session end 2025
• SB 605 Relating to: housing and homelessness; emergency rental assistance program; indigent civil legal services; workforce development; community action agencies; poverty reports; mental health; economic security; reimbursement for nonemergency medical transportation services; urban mass transit aid; lead exposure and abatement services; lead service line replacement; providing an exemption from emergency rule procedures; granting rule-making authority; and making an appropriation. (FE) Died at session end 2025
• SB 632 Relating to: naturopathic doctors. (FE) Died at session end 2025
• SB 644 Relating to: prohibiting individuals under age 21 from accessing intoxicating hemp products and providing a penalty. (FE) Died at session end 2025
• SB 734 Relating to: prescription, use, and disposal of abortion-inducing drugs and providing a penalty. Died at session end 2025
• SB 764 Relating to: cost-sharing cap on epinephrine delivery systems under health insurance policies and plans. (FE) Died at session end 2025
• SB 765 Relating to: prohibiting step therapy protocols for certain cancer drugs. Died at session end 2025
• SB 901 Relating to: cost-sharing cap on insulin. Died at session end 2025
• SB 987 Relating to: the drug repository program. Died at session end 2025
• AB 1040 Relating to: maintaining a supply of usable opioid antagonist at a public or private school and making an appropriation. (FE) Died at session end 2025
• AB 1081 Relating to: modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE) Died at session end 2025
• AB 1100 Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE) Died at session end 2025
• AB 1164 Relating to: permitting certain qualified individuals to make a request for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2025
• AB 1170 Relating to: prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE) Died at session end 2025
• AB 1228 Relating to: incorporating awareness about fentanyl and the use of an opioid antagonist into school district educational goals. (FE) Died at session end 2025
• SB 1013 Relating to: maintaining a supply of usable opioid antagonist at a public or private school and making an appropriation. (FE) Died at session end 2025
• SB 1032 Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE) Died at session end 2025
• SB 1047 Relating to: modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE) Died at session end 2025
• SB 1114 Relating to: permitting certain qualified individuals to make a request for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2025
• SB 1149 Relating to: prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE) Died at session end 2025
• SB 1174 Relating to: incorporating awareness about fentanyl and the use of an opioid antagonist into school district educational goals. (FE) Died at session end 2025
• AB 9 Relating to: use of epinephrine delivery systems and standing orders for epinephrine. (FE) Died at session end 2023
• SB 7 Relating to: use of epinephrine delivery systems and standing orders for epinephrine. (FE) Became law 2023
• AB 43 Relating to: state finances and appropriations, constituting the executive budget act of the 2023 legislature. (FE) Died at session end 2023
• SB 70 Relating to: state finances and appropriations, constituting the executive budget act of the 2023 legislature. (FE) Became law 2023
• AB 103 Relating to: application of prescription drug payments to health insurance cost-sharing requirements. Died at session end 2023
• AB 154 Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Died at session end 2023
• AB 223 Relating to: maintaining a supply of usable opioid antagonist at a school. (FE) Became law 2023
• AB 259 Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE) Died at session end 2023
• AB 445 Relating to: identification presentation for certain prescription drugs. Died at session end 2023
• AB 450 Relating to: ready-to-use glucagon rescue therapies in schools. Died at session end 2023
• AB 584 Relating to: cost-sharing cap on insulin. Died at session end 2023
• AB 626 Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE) Died at session end 2023
• AB 654 Relating to: utilization management controls for prescription drugs to treat mental illness under the Medical Assistance program. (FE) Died at session end 2023
• AB 687 Relating to: value-based purchasing arrangements under the Medical Assistance program. (FE) Died at session end 2023
• AB 747 Relating to: creating a Prescription Drug Affordability Review Board, funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, granting rulemaking authority, and making an appropriation. (FE) Died at session end 2023
• AB 748 Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) Died at session end 2023
• AB 753 Relating to: creating a medicinal psilocybin treatment fund and a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome at the University of Wisconsin-Madison and making an appropriation. (FE) Died at session end 2023
• AB 773 Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) Died at session end 2023
• AB 777 Relating to: the elimination of certain abortion-related regulations. Died at session end 2023
• AB 781 Relating to: permitting certain qualified individuals to make a request for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2023
• AB 836 Relating to: prohibiting step therapy protocols for certain cancer drugs. Died at session end 2023
• AB 848 Relating to: epinephrine for ambulances and making an appropriation. (FE) Died at session end 2023
• AB 849 Relating to: therapeutic interchange for drug products prescribed to counteract anaphylaxis. Died at session end 2023
• AB 914 Relating to: the supply and use of short-acting bronchodilators on school premises or at a school-sponsored event. Became law 2023
• SB 100 Relating to: application of prescription drug payments to health insurance cost-sharing requirements. Died at session end 2023
• SB 145 Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Vetoed 2023
• SB 206 Relating to: maintaining a supply of usable opioid antagonist at a school. (FE) Died at session end 2023
• SB 263 Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE) Became law 2023
• SB 441 Relating to: identification presentation for certain prescription drugs. Died at session end 2023
• SB 447 Relating to: ready-to-use glucagon rescue therapies in schools. Became law 2023
• SB 574 Relating to: cost-sharing cap on insulin. Died at session end 2023
• SB 618 Relating to: utilization management controls for prescription drugs to treat mental illness under the Medical Assistance program. (FE) Died at session end 2023
• SB 672 Relating to: value-based purchasing arrangements under the Medical Assistance program. (FE) Became law 2023
• SB 705 Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE) Died at session end 2023
• SB 718 Relating to: creating a Prescription Drug Affordability Review Board, funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, granting rulemaking authority, and making an appropriation. (FE) Died at session end 2023
• SB 719 Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) Died at session end 2023
• SB 727 Relating to: creating a medicinal psilocybin treatment fund and a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome at the University of Wisconsin-Madison and making an appropriation. (FE) Died at session end 2023
• SB 734 Relating to: the elimination of certain abortion-related regulations. Died at session end 2023
• SB 737 Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) Died at session end 2023
• SB 739 Relating to: permitting certain qualified individuals to make a request for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2023
• SB 782 Relating to: epinephrine for ambulances and making an appropriation. (FE) Died at session end 2023
• SB 783 Relating to: therapeutic interchange for drug products prescribed to counteract anaphylaxis. Died at session end 2023
• SB 807 Relating to: prohibiting step therapy protocols for certain cancer drugs. Died at session end 2023
• SB 854 Relating to: the supply and use of short-acting bronchodilators on school premises or at a school-sponsored event. Died at session end 2023
• SB 935 Relating to: cost-sharing cap on epinephrine auto-injectors under health insurance policies and plans. Died at session end 2023
• SB 974 Relating to: recovery of law enforcement agency costs for administration of naloxone or another opioid antagonist. (FE) Died at session end 2023
• AB 1040 Relating to: medical cannabis, granting rule-making authority, and providing a penalty. (FE) Died at session end 2023
• AB 1044 Relating to: cost-sharing cap on epinephrine auto-injectors under health insurance policies and plans. Died at session end 2023
• AB 1058 Relating to: recovery of law enforcement agency costs for administration of naloxone or another opioid antagonist. (FE) Died at session end 2023
• AB 1134 Relating to: prescription drug cost reporting by manufacturers and providing a penalty. Died at session end 2023
• AB 1188 Relating to: funding the Drug Evaluation and Classification Program and making an appropriation. (FE) Died at session end 2023
• SB 1032 Relating to: prescription drug cost reporting by manufacturers and providing a penalty. Died at session end 2023
• AB 1 Relating to: state government actions to address the COVID-19 pandemic, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Vetoed 2021
• AB 4 Relating to: pharmacy technicians and pharmacy students administering vaccines. Became law 2021
• AB 7 Relating to: pharmacy benefit managers, prescription drug benefits, and granting rule-making authority. (FE) Died at session end 2021
• SB 3 Relating to: pharmacy benefit managers, prescription drug benefits, and granting rule-making authority. (FE) Became law 2021
• AB 31 Relating to: state government response to COVID-19 pandemic, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE) Died at session end 2021
• AB 41 Relating to: opioid and methamphetamine data system and making an appropriation. (FE) Died at session end 2021
• AB 68 Relating to: state finances and appropriations, constituting the executive budget act of the 2021 legislature. (FE) Became law 2021
• SB 49 Relating to: opioid and methamphetamine data system and making an appropriation. (FE) Became law 2021
• AB 120 Relating to: third-party logistics providers, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Became law 2021
• AB 184 Relating to: application of prescription drug payments to health insurance cost-sharing requirements. Died at session end 2021
• AB 225 Relating to: reckless handling of a vaccine or drug and providing a penalty. Died at session end 2021
• AB 334 Relating to: drug testing of law enforcement officers involved in certain critical incidents while on duty. (FE) Died at session end 2021
• AB 337 Relating to: use of epinephrine prefilled syringes and standing orders for epinephrine. (FE) Became law 2021
• AB 358 Relating to: regulating the sale of items that are qualified medical expenses below cost. (FE) Died at session end 2021
• AB 374 Relating to: settlement of the multidistrict opiate litigation. Became law 2021
• AB 430 Relating to: reviewing patient records under the prescription drug monitoring program. Died at session end 2021
• AB 444 Relating to: expanding eligibility under the Medical Assistance program; funding infrastructure, land acquisition, and building projects; providing assistance and local government grants; maintaining an opioid and methamphetamine data system; transferring moneys to the budget stabilization fund; creating a University of Wisconsin System partnership program and admissions application fees; providing an exemption from rule-making procedures; and making an appropriation. (FE) Died at session end 2021
• AB 512 Relating to: prescription drug cost reporting by manufacturers and providing a penalty. Died at session end 2021
• AB 544 Relating to: creating a prescription drug affordability review board and granting rule-making authority. (FE) Died at session end 2021
• AB 546 Relating to: Wisconsin drug repository program. (FE) Died at session end 2021
• AB 548 Relating to: prescription drug importation program. (FE) Died at session end 2021
• AB 549 Relating to: pharmacy benefits tool grants, education and higher education funding, and making an appropriation. (FE) Died at session end 2021
• AB 550 Relating to: reimbursements for certain 340B program entities. (FE) Died at session end 2021
• AB 551 Relating to: diabetes medication pilot project and granting rule-making authority. (FE) Died at session end 2021
• AB 552 Relating to: cost-sharing cap on insulin. Died at session end 2021
• AB 556 Relating to: funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, and making an appropriation. (FE) Died at session end 2021
• AB 557 Relating to: insulin safety net programs and providing a penalty. (FE) Died at session end 2021
• AB 558 Relating to: prescription drug purchasing entity study. Died at session end 2021
• AB 559 Relating to: eliminating cost sharing for prescription drugs under the Medical Assistance program. (FE) Died at session end 2021
• AB 593 Relating to: informed consent regarding a certain abortion-inducing drug regimen and reporting requirements for induced abortions. Died at session end 2021
• AB 599 Relating to: regulating kratom products, granting rule-making authority, and providing a penalty. (FE) Died at session end 2021
• AB 718 Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs. Died at session end 2021
• AB 740 Relating to: epinephrine for ambulances; therapeutic interchange for drug products prescribed to counteract anaphylaxis; funding for special education, the University of Wisconsin System, and the technical college system; and making an appropriation. (FE) Died at session end 2021
• AB 745 Relating to: prohibiting step therapy protocols for certain cancer drugs. Died at session end 2021
• AB 845 Relating to: medication-assisted treatment expansion. (FE) Died at session end 2021
• AB 979 Relating to: right to try off-label therapies. (FE) Died at session end 2021
• SB 111 Relating to: state finances and appropriations, constituting the executive budget act of the 2021 legislature. (FE) Died at session end 2021
• SB 130 Relating to: prescription drug limits. Died at session end 2021
• SB 144 Relating to: third-party logistics providers, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Died at session end 2021
• SB 149 Relating to: prescription order extensions. Died at session end 2021
• SB 163 Relating to: third-party logistics providers, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) Died at session end 2021
• SB 215 Relating to: application of prescription drug payments to health insurance cost-sharing requirements. Died at session end 2021
• SB 242 Relating to: reckless handling of a vaccine or drug and providing a penalty. Became law 2021
• SB 343 Relating to: use of epinephrine prefilled syringes and standing orders for epinephrine. (FE) Died at session end 2021
• SB 357 Relating to: regulating the sale of items that are qualified medical expenses below cost. (FE) Died at session end 2021
• SB 386 Relating to: settlement of the multidistrict opiate litigation. Died at session end 2021
• SB 407 Relating to: reviewing patient records under the prescription drug monitoring program. Died at session end 2021
• SB 439 Relating to: expanding eligibility under the Medical Assistance program; funding infrastructure, land acquisition, and building projects; providing assistance and local government grants; maintaining an opioid and methamphetamine data system; transferring moneys to the budget stabilization fund; creating a University of Wisconsin System partnership program and admissions application fees; providing an exemption from rule-making procedures; and making an appropriation. (FE) Died at session end 2021
• SB 476 Relating to: drug testing of law enforcement officers involved in certain critical incidents while on duty. (FE) Died at session end 2021
• SB 499 Relating to: prescription drug cost reporting by manufacturers and providing a penalty. Died at session end 2021
• SB 539 Relating to: prescription drug importation program. (FE) Died at session end 2021
• SB 540 Relating to: creating a prescription drug affordability review board and granting rule-making authority. (FE) Died at session end 2021
• SB 542 Relating to: reimbursements for certain 340B program entities. (FE) Died at session end 2021
• SB 546 Relating to: cost-sharing cap on insulin. Died at session end 2021
• SB 550 Relating to: diabetes medication pilot project and granting rule-making authority. (FE) Died at session end 2021
• SB 551 Relating to: prescription drug purchasing entity study. Died at session end 2021
• SB 552 Relating to: eliminating cost sharing for prescription drugs under the Medical Assistance program. (FE) Died at session end 2021
• SB 553 Relating to: insulin safety net programs and providing a penalty. (FE) Died at session end 2021
• SB 554 Relating to: pharmacy benefits tool grants and making an appropriation. (FE) Died at session end 2021
• SB 577 Relating to: Wisconsin drug repository program. (FE) Died at session end 2021
• SB 578 Relating to: funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, and making an appropriation. (FE) Died at session end 2021
• SB 591 Relating to: informed consent regarding a certain abortion-inducing drug regimen and reporting requirements for induced abortions. Vetoed 2021
• SB 706 Relating to: epinephrine for ambulances; therapeutic interchange for drug products prescribed to counteract anaphylaxis; funding for special education, the University of Wisconsin System, and the technical college system; and making an appropriation. (FE) Died at session end 2021
• SB 716 Relating to: prohibiting step therapy protocols for certain cancer drugs. Died at session end 2021
• SB 753 Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs. Died at session end 2021
• SB 958 Relating to: regulating kratom products, granting rule-making authority, and providing a penalty. (FE) Died at session end 2021
• AB 1033 Relating to: obsolete statutory references; electronic assessment rolls; obsolete tax benefits for the purchase of Internet equipment used in the broadband market; board of review provision related to an objector; the sales tax exemption for insulin; and sales tax exemption certificates for farm-raised fish and patient health care records (suggested as remedial legislation by the Department of Revenue). Died at session end 2021
• AB 1067 Relating to: medical marijuana, granting rule-making authority, and providing a penalty. (FE) Died at session end 2021
• AB 1078 Relating to: permitting certain qualified individuals to make a request for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2021
• AB 1141 Relating to: funding the Drug Evaluation and Classification Program and making an appropriation. (FE) Died at session end 2021
• SB 1013 Relating to: permitting certain qualified individuals to make a request for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2021
• SB 1020 Relating to: obsolete statutory references; electronic assessment rolls; obsolete tax benefits for the purchase of Internet equipment used in the broadband market; board of review provision related to an objector; the sales tax exemption for insulin; and sales tax exemption certificates for farm-raised fish and patient health care records (suggested as remedial legislation by the Department of Revenue). Died at session end 2021
• SB 1033 Relating to: medication-assisted treatment expansion. (FE) Died at session end 2021
• SB 1034 Relating to: medical marijuana, granting rule-making authority, and providing a penalty. (FE) Died at session end 2021
• AB 24 Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority. Died at session end 2019
• AB 42 Relating to: dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis. Died at session end 2019
• AB 56 Relating to: state finances and appropriations, constituting the executive budget act of the 2019 legislature. Became law 2019
• AB 62 Relating to: manufacturer and insurer disclosure of prescription drug costs. Died at session end 2019
• SB 22 Relating to: regulating the sale of prescription drugs below cost. (FE) Died at session end 2019
• SB 26 Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority. Became law 2019
• SB 38 Relating to: dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis. Became law 2019
• SB 52 Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE) Died at session end 2019
• SB 59 Relating to: state finances and appropriations, constituting the executive budget act of the 2019 legislature. Died at session end 2019
• AB 139 Relating to: reporting of naloxone administration by ambulance service providers. (FE) Died at session end 2019
• AB 154 Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE) Died at session end 2019
• AB 156 Relating to: regulating the sale of prescription drugs below cost. (FE) Died at session end 2019
• AB 180 Relating to: informed consent regarding a certain abortion-inducing drug regimen and reporting requirements for induced abortions. Vetoed 2019
• AB 411 Relating to: cost sharing for insulin under health insurance policies and plans. Died at session end 2019
• AB 552 Relating to: permitting certain individuals to make requests for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2019
• AB 645 Relating to: opioid antagonist administration in jails and medication-assisted treatment availability in prisons and jails. (FE) Became law 2019
• AB 647 Relating to: the prescription drug monitoring program. (FE) Became law 2019
• AB 653 Relating to: providing medication and a valid prescription to a prisoner upon release. (FE) Died at session end 2019
• AB 750 Relating to: medical marijuana, granting rule-making authority, and providing a penalty. (FE) Died at session end 2019
• AB 839 Relating to: use of epinephrine prefilled syringes and standing order for epinephrine. (FE) Died at session end 2019
• AB 862 Relating to: opioid settlement moneys and creation of opioid settlement trust fund and opioid settlement foundation. (FE) Died at session end 2019
• AB 954 Relating to: funding the Drug Evaluation and Classification Program and making an appropriation. (FE) Died at session end 2019
• SB 134 Relating to: reporting of naloxone administration by ambulance service providers. (FE) Died at session end 2019
• SB 174 Relating to: informed consent regarding a certain abortion-inducing drug regimen and reporting requirements for induced abortions. Died at session end 2019
• SB 340 Relating to: cost sharing for insulin under health insurance policies and plans. Died at session end 2019
• SB 499 Relating to: permitting certain individuals to make requests for medication for the purpose of ending their lives and providing a penalty. (FE) Died at session end 2019
• SB 581 Relating to: the prescription drug monitoring program. (FE) Died at session end 2019
• SB 592 Relating to: providing medication and a valid prescription to a prisoner upon release. (FE) Died at session end 2019
• SB 594 Relating to: opioid antagonist administration in jails and medication-assisted treatment availability in prisons and jails. (FE) Died at session end 2019
• SB 683 Relating to: medical marijuana, granting rule-making authority, and providing a penalty. (FE) Died at session end 2019
• SB 759 Relating to: use of epinephrine prefilled syringes and standing order for epinephrine. (FE) Died at session end 2019
• SB 907 Relating to: application of prescription drug payments for health coverage. Died at session end 2019
• SB 927 Relating to: regulating the sale of certain drugs and medical supplies below cost. Died at session end 2019
• SB 932 Relating to: state government response to the COVID-19 pandemic. (FE) Died at session end 2019
• AB 1011 Relating to: epinephrine for ambulances, therapeutic interchange for drug products prescribed to counteract anaphylaxis, and making an appropriation. (FE) Died at session end 2019
• AB 1035 Relating to: regulating the sale of certain drugs and medical supplies below cost. Died at session end 2019
• AB 1038 Relating to: state government response to the COVID-19 pandemic. (FE) Became law 2019
• SB 8 Relating to: waiver for prescription drug assistance for elderly program, use of excess moneys in prescription drug assistance for elderly program, and making an appropriation. (FE) Died at session end 2017
• AB 55 Relating to: waiver for prescription drug assistance for elderly program, use of excess moneys in prescription drug assistance for elderly program, and making an appropriation. (FE) Died at session end 2017
• AB 64 Relating to: state finances and appropriations, constituting the executive budget act of the 2017 legislature. Became law 2017
• AB 69 Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use. Died at session end 2017
• AB 96 Relating to: supply and use of epinephrine auto-injectors by certain authorized individuals. (FE) Became law 2017
• SB 50 Relating to: the minimum sale price of prescription drugs. (FE) Died at session end 2017
• SB 84 Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use. Became law 2017
• AB 125 Relating to: prescription order extensions for when a refill authorization cannot be obtained. Became law 2017
• AB 216 Relating to: permitting certain individuals to make requests for medication for the purpose of ending their lives and providing a criminal penalty. (FE) Died at session end 2017
• AB 306 Relating to: tracking the sale of pseudoephedrine products. Became law 2017
• AB 359 Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE) Died at session end 2017
• AB 385 Relating to: requiring controlled substance abuse screening, testing, and treatment for eligibility for economic development programs. (FE) Died at session end 2017
• AB 444 Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs. Became law 2017
• AB 467 Relating to: the distribution of prescription medication in a juvenile correctional facility or secured residential care center for children and youth. Died at session end 2017
• AB 620 Relating to: prescription drug cost reporting by manufacturers and providing a penalty. (FE) Died at session end 2017
• AB 622 Relating to: prohibiting elimination of covered prescription drugs or devices during a contract year for certain health care plans. Died at session end 2017
• AB 679 Relating to: the treatment of biological products for various purposes under the pharmacy practice law. Died at session end 2017
• AB 681 Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE) Became law 2017
• AB 707 Relating to: administration of prescription drugs by correctional officers. Died at session end 2017
• AB 790 Relating to: elimination of a provision that excepts spiritual treatment of a child in the law criminalizing physical abuse of a child and in the laws governing the practice of medicine or surgery, the investigation of child abuse or neglect, the administration of psychotropic medication to juveniles in correctional custody, and the election of Christian Science treatment in lieu of medical or surgical treatment. (FE) Died at session end 2017
• AB 800 Relating to: disclosures of prescription drug costs under health insurance policies and plans. Died at session end 2017
• AB 876 Relating to: coverage of prescription eye drop refills. Became law 2017
• AB 902 Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE) Became law 2017
• AB 907 Relating to: continuing education in prescribing controlled substances for certain health care practitioners; maintenance and detoxification treatment provided by physician assistants and advanced practice nurse prescribers; requiring school boards to provide instruction about drug abuse awareness and prevention; graduate training of psychiatric nurses; training materials for social services workers handling substance abuse-related cases; substance abuse counseling and modifying and creating administrative rules related to substance abuse counseling; granting rule-making authority; and making appropriations. (FE) Became law 2017
• SB 116 Relating to: prescription order extensions for when a refill authorization cannot be obtained. Died at session end 2017
• SB 209 Relating to: supply and use of epinephrine auto-injectors by certain authorized individuals. (FE) Died at session end 2017
• SB 237 Relating to: tracking the sale of pseudoephedrine products. Died at session end 2017
• SB 263 Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE) Died at session end 2017
• SB 312 Relating to: permitting certain individuals to make requests for medication for the purpose of ending their lives and providing a criminal penalty. (FE) Died at session end 2017
• SB 361 Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs. Died at session end 2017
• SB 377 Relating to: the distribution of prescription medication in a juvenile correctional facility or secured residential care center for children and youth. Died at session end 2017
• SB 530 Relating to: prohibiting elimination of covered prescription drugs or devices during a contract year for certain health care plans. Died at session end 2017
• SB 531 Relating to: prescription drug cost reporting by manufacturers and providing a penalty. (FE) Died at session end 2017
• SB 575 Relating to: the treatment of biological products for various purposes under the pharmacy practice law. Became law 2017
• SB 587 Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE) Died at session end 2017
• SB 595 Relating to: administration of prescription drugs by correctional officers. Died at session end 2017
• SB 669 Relating to: disclosures of prescription drug costs under health insurance policies and plans. Died at session end 2017
• SB 750 Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE) Died at session end 2017
• SB 767 Relating to: continuing education in prescribing controlled substances for certain health care practitioners; maintenance and detoxification treatment provided by physician assistants and advanced practice nurse prescribers; requiring school boards to provide instruction about drug abuse awareness and prevention; graduate training of psychiatric nurses; training materials for social services workers handling substance abuse-related cases; substance abuse counseling and modifying and creating administrative rules related to substance abuse counseling; granting rule-making authority; and making appropriations. (FE) Died at session end 2017
• SB 771 Relating to: coverage of prescription eye drop refills. Died at session end 2017
• SB 874 Relating to: price restrictions for certain off-patent or generic drugs and providing a penalty. (FE) Died at session end 2017
• SB 875 Relating to: dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis. Died at session end 2017
• AB 1046 Relating to: price restrictions for certain off-patent or generic drugs and providing a penalty. (FE) Died at session end 2017
• AB 1047 Relating to: dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis. Died at session end 2017
• AB 15 Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE) Died at session end 2015
• AB 21 Relating to: state finances and appropriations, constituting the executive budget act of the 2015 legislature. Died at session end 2015
• AB 67 Relating to: permitting certain individuals to make requests for medication for the purpose of ending their lives and providing penalties. (FE) Died at session end 2015
• AB 96 Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures. Died at session end 2015
• SB 15 Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE) Became law 2015
• SB 18 Relating to: the manufacture, sale, and distribution of products containing microbeads and providing a penalty. (FE) Died at session end 2015
• SB 21 Relating to: state finances and appropriations, constituting the executive budget act of the 2015 legislature. Became law 2015
• SB 28 Relating to: permitting certain individuals to make requests for medication for the purpose of ending their lives and providing penalties. (FE) Died at session end 2015
• SB 74 Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures. Became law 2015
• SB 84 Relating to: creating a Corrections System Formulary Board in the Department of Corrections, therapeutic alternate drug selections in the state correctional system, and granting rule-making authority. (FE) Became law 2015
• AB 120 Relating to: creating a Corrections System Formulary Board in the Department of Corrections, therapeutic alternate drug selections in the state correctional system, and granting rule-making authority. (FE) Died at session end 2015
• AB 179 Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use. Died at session end 2015
• AB 191 Relating to: requiring drug testing and treatment for eligibility for certain work experience programs; requiring the Department of Health Services to request a waiver to screen and, if indicated, test and provide treatment to FoodShare employment and training participants for illegal use of a controlled substance; and making an appropriation. (FE) Died at session end 2015
• AB 192 Relating to: requiring certain unemployment insurance claimants to submit to drug tests, eligibility for unemployment insurance benefits following a drug test, granting rule-making authority, and making an appropriation. (FE) Died at session end 2015
• AB 203 Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE) Died at session end 2015
• AB 211 Relating to: waiver for prescription drug assistance for elderly program, use of excess moneys in prescription drug assistance for elderly program, and making an appropriation. (FE) Died at session end 2015
• AB 311 Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE) Died at session end 2015
• AB 364 Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE) Became law 2015
• AB 365 Relating to: duty of law enforcement officers to report to the Prescription Drug Monitoring Program controlled-substance violations, opioid-related drug overdoses or deaths, and reports of stolen prescription drugs. (FE) Became law 2015
• AB 366 Relating to: pain clinic certification and requirements, granting rule-making authority, and providing a penalty. (FE) Became law 2015
• AB 367 Relating to: reporting by treatment programs using methadone and requiring review of prescription drug monitoring database. Became law 2015
• AB 427 Relating to: prescription, dispensing, and delivery of opioid antagonists. Became law 2015
• AB 501 Relating to: various changes to the worker's compensation law, granting rule-making authority, and making an appropriation. (FE) Died at session end 2015
• AB 573 Relating to: declarations of domestic partnership and marriage licenses. (FE) Became law 2015
• AB 659 Relating to: opioid treatment programs. (FE) Became law 2015
• AB 660 Relating to: guidelines for prescribing controlled substances and the examination authority of the Medical Examining Board. Became law 2015
• AB 679 Relating to: volunteer health care provider program, changing reference to residential treatment programs, and eliminating a grammatical error in the Well-Woman Program provision on specialized training for rural colposcopic examinations (suggested as remedial legislation by the Department of Health Services). Became law 2015
• AB 724 Relating to: various changes to the worker's compensation law, granting rule-making authority, and making an appropriation. (FE) Became law 2015
• AB 766 Relating to: review and reporting requirements for the Prescription Drug Monitoring Program. (FE) Became law 2015
• AB 776 Relating to: permits issued to a state crime laboratory to possess, manufacture, or use a controlled substance. Became law 2015
• AB 791 Relating to: informed consent for psychotropic medications in nursing homes and community-based residential facilities. (FE) Died at session end 2015
• AB 835 Relating to: administration of prescription drugs by correctional officers. Died at session end 2015
• AB 865 Relating to: the administration by injection of prescribed drugs by pharmacists. (FE) Became law 2015
• AB 866 Relating to: prescription refills. Became law 2015
• AB 959 Relating to: elimination of a provision that excepts spiritual treatment of a child in the law criminalizing physical abuse of a child and in the laws governing the practice of medicine or surgery, the investigation of child abuse or neglect, the administration of psychotropic medication to juveniles in correctional custody, and the election of Christian Science treatment in lieu of medical or surgical treatment. (FE) Died at session end 2015
• SB 125 Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use. Died at session end 2015
• SB 139 Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE) Became law 2015
• SB 142 Relating to: waiver for prescription drug assistance for elderly program, use of excess moneys in prescription drug assistance for elderly program, and making an appropriation. (FE) Died at session end 2015
• SB 238 Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE) Became law 2015
• SB 268 Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE) Died at session end 2015
• SB 269 Relating to: duty of law enforcement officers to report to the Prescription Drug Monitoring Program controlled-substance violations, opioid-related drug overdoses or deaths, and reports of stolen prescription drugs. (FE) Died at session end 2015
• SB 271 Relating to: reporting by treatment programs using methadone and requiring review of prescription drug monitoring database. Died at session end 2015
• SB 345 Relating to: prescription, dispensing, and delivery of opioid antagonists. Died at session end 2015
• SB 456 Relating to: various changes to the worker's compensation law, granting rule-making authority, and making an appropriation. (FE) Died at session end 2015
• SB 465 Relating to: declarations of domestic partnership and marriage licenses. (FE) Died at session end 2015
• SB 520 Relating to: guidelines for prescribing controlled substances and the examination authority of the Medical Examining Board. Died at session end 2015
• SB 522 Relating to: opioid treatment programs. (FE) Died at session end 2015
• SB 536 Relating to: various changes to the worker's compensation law, granting rule-making authority, and making an appropriation. (FE) Died at session end 2015
• SB 554 Relating to: volunteer health care provider program, changing reference to residential treatment programs, and eliminating a grammatical error in the Well-Woman Program provision on specialized training for rural colposcopic examinations (suggested as remedial legislation by the Department of Health Services). Died at session end 2015
• SB 611 Relating to: administration of prescription drugs by correctional officers. Died at session end 2015
• SB 623 Relating to: permits issued to a state crime laboratory to possess, manufacture, or use a controlled substance. Died at session end 2015
• SB 708 Relating to: the administration by injection of prescribed drugs by pharmacists. (FE) Died at session end 2015
• SB 709 Relating to: prescription refills. Died at session end 2015
• SB 716 Relating to: review and reporting requirements for the Prescription Drug Monitoring Program. (FE) Died at session end 2015
• SB 748 Relating to: informed consent for psychotropic medications in nursing homes and community-based residential facilities. (FE) Died at session end 2015
• AB 3 Relating to: the exclusion of veterinarians from the prescription drug monitoring program. Became law 2013
• SB 7 Relating to: the exclusion of veterinarians from the prescription drug monitoring program. Died at session end 2013
• AB 40 Relating to: state finances and appropriations, constituting the executive budget act of the 2013 legislature. (FE) Became law 2013
• AB 292 Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy. Died at session end 2013
• AB 408 Relating to: a dental hygienist's administration of nitrous oxide inhalation analgesia and practice of dental hygiene. (FE) Died at session end 2013
• AB 433 Relating to: the authority and responsibilities of the Department of Safety and Professional Services and the various boards under that department, the membership of the Cosmetology Examining Board, professional licensure of pharmacists, the Pharmacy Examining Board's operation of the prescription drug monitoring program, authorizing the construction, installation, alteration, operation, and inspection of elevators and other similar conveyances, and licensing requirements for elevator mechanics, inspectors, and contractors. (FE) Died at session end 2013
• AB 436 Relating to: requiring county community programs board appointees to include consumers, family members of consumers, law enforcement personnel, and hospital employees or representatives and increasing the size of county community programs boards. Died at session end 2013
• AB 445 Relating to: identification presentation and monitoring for certain prescription drugs. (FE) Became law 2013
• AB 446 Relating to: training and agreements for administering the drug naloxone, requiring emergency medical technicians to carry naloxone, and immunity for certain individuals who administer naloxone. (FE) Became law 2013
• AB 448 Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE) Became law 2013
• AB 502 Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity. Died at session end 2013
• AB 544 Relating to: a pupil's possession and use of an epinephrine auto-injector. Died at session end 2013
• AB 575 Relating to: psychiatric and behavioral care and treatment for individuals with dementia, dementia care units, and providing a penalty. (FE) Died at session end 2013
• AB 630 Relating to: elimination of a provision that excepts spiritual treatment of a child in the law criminalizing physical abuse of a child and in the laws governing the practice of medicine or surgery, the investigation of child abuse or neglect, the administration of psychotropic medication to juveniles in correctional custody, and the election of Christian Science treatment in lieu of medical or surgical treatment. (FE) Died at session end 2013
• AB 675 Relating to: evaluation of infants for fetal alcohol spectrum disorder and referral of infants who have that condition for services and treatment. (FE) Became law 2013
• AB 701 Relating to: opioid treatment programs and making an appropriation. (FE) Became law 2013
• AB 711 Relating to: various changes to the worker's compensation law, granting rule-making authority, and making an appropriation. (FE) Died at session end 2013
• AB 775 Relating to: administration of medications at a camp. Died at session end 2013
• SB 128 Relating to: requiring county community programs board appointees to include consumers, family members of consumers, law enforcement personnel, and hospital employees or representatives and increasing the size of county community programs boards. Died at session end 2013
• SB 159 Relating to: waiver for prescription drug assistance for elderly program, use of excess moneys in prescription drug assistance for elderly program, and making an appropriation. (FE) Died at session end 2013
• SB 251 Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy. Became law 2013
• SB 311 Relating to: a dental hygienist's administration of nitrous oxide inhalation analgesia and practice of dental hygiene. (FE) Became law 2013
• SB 345 Relating to: the authority and responsibilities of the Department of Safety and Professional Services and the various boards under that department, the membership of the Cosmetology Examining Board, professional licensure of pharmacists, the Pharmacy Examining Board's operation of the prescription drug monitoring program, authorizing the construction, installation, alteration, operation, and inspection of elevators and other similar conveyances, and licensing requirements for elevator mechanics, inspectors, and contractors. (FE) Became law 2013
• SB 351 Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE) Died at session end 2013
• SB 353 Relating to: identification presentation and monitoring for certain prescription drugs. (FE) Died at session end 2013
• SB 375 Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity. Became law 2013
• SB 403 Relating to: care needs provided by veterans homes. Died at session end 2013
• SB 416 Relating to: a pupil's possession and use of an epinephrine auto-injector. Died at session end 2013
• SB 541 Relating to: opioid treatment programs and making an appropriation. (FE) Died at session end 2013
• SB 550 Relating to: various changes to the worker's compensation law, granting rule-making authority, and making an appropriation. (FE) Died at session end 2013
• SB 553 Relating to: administration of medications at a camp. Became law 2013
• SB 607 Relating to: misuse of a prescribed controlled substance and providing a penalty. (FE) Died at session end 2013